Trials / Not Yet Recruiting
Not Yet RecruitingNCT07364019
The Brain Health PRO Online Risk Factor Reduction Study to Prevent Dementia
The Brain Health PRO Online Risk Factor Reduction Study for The Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 700 (estimated)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study will recruit participants at risk for dementia to participate in an online educational program called Brain Health PRO (BHPro). The BHPro intervention is designed to address modifiable risk factors for dementia through a 6-month, fully online, educational program conveying the best available evidence for lifestyle changes that can mitigate dementia risk, and foster engagement toward one's own brain health. Achieving lifestyle changes in a diverse Canadian population through online education would be a major achievement in dementia prevention in Canada, with widespread personal and socioeconomic benefits. Eligible participants will be randomly assigned to either start Brain Health PRO immediately or in 6 months (delayed-start control group). All participants will have the opportunity to have access to BHPro for 6 months during the course of the study and will have open access to all content for 12 months following the initial 6-month intervention. Participation will last from 18-24 months depending on group assignment.
Conditions
- Dementia Prevention
- Subjective Cognitive Impairment
- Mild Cognitive Impairment
- Cognitive Change
- Lifestyle Intervention
- Dementia Education
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Brain Health PRO | Immediate start of 6-month Brain Health PRO Intervention |
| OTHER | Brain Health PRO | Delayed start of 6-month Brain Health PRO |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2028-10-31
- Completion
- 2028-10-31
- First posted
- 2026-01-23
- Last updated
- 2026-01-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT07364019. Inclusion in this directory is not an endorsement.